Abstract:Therapeutic Advances in Drug Safety, Volume 15, Issue , January-December 2024. Background:Inappropriate medication prescribing in older patients increases the risk of poorer health outcomes and increased costs. The IMMENSE trial, integrated a clinical pharmacist into the health care team, to improve medication therapy among older patients, and to investigate the impact on acute revisits to hospital.Objectives:This study investigated the prevalence of potentially inappropriate medications (PIMs) and prescribing omissions (PPOs) at hospital admission and discharge. It also explored the impact of the pharmacist intervention on PIMs and PPOs, and other factors associated with PIMs and PPOs at discharge.Design:The STOPP/START criteria version 2 were retrospectively applied at admission and discharge. PIM and PPO changes were compared, and Poisson regression was used to assess factors influencing prevalence at discharge.Results:At hospital admission, PIM prevalence was 58.6% among intervention patients and 64.8% among control patients. PPO prevalence was 55.3% and 55.5%, respectively. A larger proportion of PIMs identified at admission were resolved by discharge in the intervention group (42.9%) compared to the control group (27.4%). No difference was seen for PPOs. Poisson regression identified a significantly higher risk for PIMs at discharge in the control group compared to the intervention group (IRR 1.255; 95% CI 1.063–1.480, p = 0.007), but no effect for PPOs. Patients living in a nursing home, a home care facility, or an institution showed a higher risk of PPOs at discharge compared to patients living at home (IRR 1.378; 95% CI 1.156–1.644, p < 0.001).Conclusion:The IMMENSE intervention significantly reduced the risk of PIMs at discharge, with no effect on PPOs. Living in nursing homes, home care facilities, or institutions prior to hospitalization increased the risk of PPOs at discharge. Pharmacists may contribute to improved medication appropriateness in older hospitalized patients.Plain language summaryHow a pharmacist's contribution in a hospital ward can reduce inappropriate medication prescribing in older patients: insights from a studyWhy Was This Study Done? The IMMENSE trial explored whether integrating a clinical pharmacist into the healthcare team could reduce inappropriate medications and improve health outcomes for older patients, potentially decreasing unnecessary hospital revisits.What Did the Researchers Do? The researchers assessed the presence of potentially inappropriate medications (PIMs) and prescribing omissions (PPOs) at hospital admission and discharge. They used the STOPP/START criteria to evaluate medication lists to compare changes and understand factors influencing these issues at discharge.What Did the Researchers Find? The study revealed that 57-65% of patients had inappropriate medications, and 55-57% experienced prescribing omissions during their hospital stay. Patients in the group with a pharmacist on their healthcare team had a significant reduction in PIMs at discharge. However, there was no significant change in PPOs. Additionally, patients from nursing homes or similar facilities were more likely to have PPOs at discharge compared to those living at home.What Do the Findings Mean? The findings suggest that including a pharmacist in the healthcare team significantly helps in reducing inappropriate medications among hospitalized older patients, enhancing medication safety. However, the intervention did not significantly affect prescribing omissions. This indicates a need for targeted strategies to address omissions, especially for patients in nursing homes or care facilities. The role of pharmacists is crucial in improving medication management and safety in hospital settings, particularly for the elderly.

Introducing a pharmacist-led transmural care program to reduce drug-related problems in orthogeriatric patients: a prospective interventional study

Pharmaceutical Interventions by Collaboration Between Staff Pharmacists and Clinical Pharmacists and Implementation of Joint Commission International Accreditation Standards on Medication Use May Optimize Pharmacotherapy in Geriatric Patients

Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome

A collaborative pharmacist-led intervention to prevent hospital readmissions among elderly patients discharged from the emergency department: a retrospective cohort study

Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation

Clinical Pharmacy Services in Older Inpatients: An Evidence-Based Review

Evaluation of pharmacist-led transition of care program in patients with acute coronary syndrome

Frail older people with multi-morbidities in primary care: a new integrated care clinical pharmacy service

Implementation of interprofessional pharmaceutical care initiatives: lessons learned from successful bottom-up initiatives in primary care

Advancing Pharmacy Practice through an Innovative Ambulatory Care Transitions Program at an Academic Medical Center

Identification of drug-related problems during pharmaceutical care services: Introduction to the Geriatric Department at the University medical center

Feasibility of optimizing pharmacotherapy in heart failure patients admitted to an acute geriatric ward: role of the clinical pharmacist

Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol

Evaluation of a pharmacist-led intervention to reduce drug-related problems in patients included in a home healthcare program: study protocol for a pragmatic randomized clinical trial

Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices-results of a cluster-randomized controlled trial

Community pharmacy transition of care services and rural hospital readmissions: A case study

Investigating the impact of a pharmacist intervention on inappropriate prescribing practices at hospital admission and discharge in older patients: a secondary outcome analysis from a randomized controlled trial

Description and Outcomes of a Palliative Care Pharmacist-Led Transitions of Care Program

A mixed methods analysis of the medication review intervention centered around the use of the 'Systematic Tool to Reduce Inappropriate Prescribing' Assistant (STRIPA) in Swiss primary care practices

Evaluation of Pharmacy Resident-Driven Medication Reconciliation on Patients at High Risk of Hospital Readmission

Providing information about medication changes upon discharge from a geriatric unit: the community healthcare professionals' point of view